Inventor
Zhicai Wu
Inventor
Montvale, NJ, US
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides5%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C07CAcyclic or carbocyclic compounds1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,875,851Factor XIIa inhibitors202010,800,827Insulin receptor partial agonists202010,689,430Insulin receptor partial agonists202010,508,108Tricyclic compounds as inhibitors of mutant IDH enzymes201910,442,819Tricyclic compounds as inhibitors of mutant IDH enzymes201910,183,981Insulin receptor partial agonists201910,017,556Insulin receptor partial agonists20189,868,733'Azabenzimidazole tetrahydrofuran derivatives'20189,751,881'Inhibitors of the renal outer medullary potassium channel'20179,556,193'Benzimidazole hexahydrofuro[3,2-b]furan derivatives'20179,540,364'Benzimidazole tetrahydrofuran derivatives'20179,527,839'Benzimidazole tetrahydropyran derivatives'20169,505,730'Mineralocorticoid receptor antagonists'20169,469,608'Thrombin inhibitors'20169,403,807'Mineralocorticoid receptor antagonists'20169,382,243'Azabenzimidazole tetrahydropyran derivatives'20169,365,539'Prolylcarboxypeptidase inhibitors'20169,340,530'Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists'20169,290,517'Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives'20169,206,198'Inhibitors of the renal outer medullary potassium channel'20158,952,166'Inhibitors of the renal outer medullary potassium channel'20158,933,113'Mineralocorticoid receptor antagonists'20158,796,258'Cyclic azabenzimidazole derivatives useful as anti-diabetic agents'20148,030,332'Potassium channel inhibitors'20117,879,839'Potassium channel inhibitors'20117,750,151'Inhibitors of Akt activity'20107,638,530'Inhibitors of Akt activity'20097,579,355'Inhibitors of Akt activity'20097,569,589'Potassium channel inhibitors'20097,544,677'Inhibitors of Akt activity'20097,414,055'Inhibitors of Akt activity'20087,223,738'Inhibitors of Akt activity'20077,125,888'Tyrosine kinase inhibitors'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2009Patents assigned to MERCK & CO INC (7)· patent assignee history
2006–2011Based in Quakertown, PA, US· patent location history
2010–2020Patents assigned to MERCK SHARP & DOHME (26)· patent assignee history
2011Based in Hillsdale, NJ, US· patent location history
2014–2020Patents assigned to WU ZHICAI (6)· patent assignee history
2014–2019Patents assigned to BIFTU TESFAYE (2)· patent assignee history
2014–2020Patents assigned to HICKS JACQUELINE D (2)· patent assignee history
2014–2020Based in Montvale, NJ, US· patent location history
2018–2020Based in Kenilworth, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 26 | 2010–2020 |
| MERCK & CO INC | 7 | 2006–2009 |
| WU ZHICAIself | 6 | 2014–2020 |
| BIFTU TESFAYE | 2 | 2014–2019 |
| HICKS JACQUELINE D | 2 | 2014–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Montvale, New Jersey, US | 19 | 2014–2020 |
| Quakertown, Pennsylvania, US | 9 | 2006–2011 |
| Kenilworth, New Jersey, US | 4 | 2018–2020 |
| Hillsdale, New Jersey, US | 1 | 2011 |